264 related articles for article (PubMed ID: 14258387)
1. THE USES AND ABUSES OF APPETITE SUPPRESSANTS.
SEATON DA; DUNCAN LJ
Br J Clin Pract; 1965 Feb; 19():89-93. PubMed ID: 14258387
[No Abstract] [Full Text] [Related]
2. A COMPARISON OF THE APPETITE SUPPRESSING PROPERTIES OF DEXAMPHETAMINE AND PHENTERMINE.
SEATON DA; ROSE K; DUNCAN LJ
Scott Med J; 1964 Nov; 9():482-5. PubMed ID: 14231545
[No Abstract] [Full Text] [Related]
3. SUSTAINED-ACTION AMPHETAMINE-MEPROBAMATE COMBINATION FOR THE TREATMENT OF OBESITY.
BATTERMAN RC
Curr Ther Res Clin Exp; 1964 Jul; 6():447-53. PubMed ID: 14203275
[No Abstract] [Full Text] [Related]
4. SUSTAINED RELEASE APPETITE SUPPRESSANT COMBINED WITH REDUCING DIET.
LERICHE WH; CSIMA A
Appl Ther; 1965 Mar; 7():226-8. PubMed ID: 14266244
[No Abstract] [Full Text] [Related]
5. APPETITE SUPPRESSING DRUGS AS AN ETIOLOGIC FACTOR IN MENTAL ILLNESS.
BREITNER C
Psychosomatics; 1963; 4():327-33. PubMed ID: 14060673
[No Abstract] [Full Text] [Related]
6. PSYCHOPHARMACOLOGY OF CHLORPHENTERMINE AND D-AMPHETAMINE. A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES.
DIMASCIO A; BUIE DH
Clin Pharmacol Ther; 1964; 5():174-84. PubMed ID: 14155159
[No Abstract] [Full Text] [Related]
7. The anorexigenic effect of sustained-release dexedrine preparations.
GELVIN EP; McGAVACK TH; KENIGSBERG S
Am J Dig Dis; 1953 Oct; 20(10):307-12. PubMed ID: 13092091
[No Abstract] [Full Text] [Related]
8. Value of ephedrine-ethlenediamine as an appetite depressant: comparison with d-amphetamine sulfate.
KUPERSMITH IH
Curr Ther Res Clin Exp; 1960 Feb; 2():39-42. PubMed ID: 14412826
[No Abstract] [Full Text] [Related]
9. USE OF AN AMPHETAMINE-COMBINATION DRUG IN AN ANTI-OBESITY CLINIC.
BERMAN MI; ANDERSON IR
Md State Med J; 1965 Jan; 14():29-31. PubMed ID: 14233312
[No Abstract] [Full Text] [Related]
10. [ON THE DRUG THERAPY OF OBESITY].
NEUBERT D
Z Arztl Fortbild (Berl); 1965 Feb; 54():134-46. PubMed ID: 14266804
[No Abstract] [Full Text] [Related]
11. COMPLICATED OBESITY: CLINICAL EVALUATION OF A TIMED-RELEASE ANORECTIC AGENT.
HOWARD LA; KLEIN HT; BERK MS
Curr Ther Res Clin Exp; 1964 Nov; 6():659-63. PubMed ID: 14240755
[No Abstract] [Full Text] [Related]
12. SYMPATHOMIMETIC DRUG-INDUCED PSYCHOSIS.
MURRAY PA
J Ir Med Assoc; 1964 Jan; 54():21-3. PubMed ID: 14105269
[No Abstract] [Full Text] [Related]
13. Evaluation of appetite suppressants.
CASS LJ
Ann Intern Med; 1959 Dec; 51():1295-302. PubMed ID: 13808189
[No Abstract] [Full Text] [Related]
14. Comparison of phentermine-amphetamine resin complex with sustained-release dextroamphetamine and placebo in the treatment of exogenous obesity.
De Felice EA; Cohen A; Schmitz PL; Rothwell KG; Truant AP
J Clin Pharmacol J New Drugs; 1968; 8(6):360-9. PubMed ID: 4883784
[No Abstract] [Full Text] [Related]
15. AMPHETAMINE AND PHENMETRAZINE ADDICTION. PHYSIOLOGICAL ABNORMALITIES IN THE ABSTINENCE SYNDROME.
OSWALD I; THACORE VR
Br Med J; 1963 Aug; 2(5354):427-31. PubMed ID: 14159321
[No Abstract] [Full Text] [Related]
16. SOME PHARMACOLOGIC PROPERTIES OF BENZPHETAMINE HYDROCHLORIDE.
VELDKAMP W; TAZELAAR AP; FREYBURGER WA; KEASLING HH
Toxicol Appl Pharmacol; 1964 Jan; 6():15-22. PubMed ID: 14105893
[No Abstract] [Full Text] [Related]
17. MANAGEMENT OF THE OBESE PATIENT: A REVIEW OF ADJUNCTIVE MEASURES.
EHRMANTRAUT WR; SAVARESE CJ
J Am Med Womens Assoc; 1964 Sep; 19():750-4. PubMed ID: 14173959
[No Abstract] [Full Text] [Related]
18. REACTIONS TO USE OF AMPHETAMINES AS OBSERVED IN A PSYCHIATRIC HOSPITAL.
PROUT CT
N Y State J Med; 1964 May; 64():1186-92. PubMed ID: 14144137
[No Abstract] [Full Text] [Related]
19. The use of a sustained-release d-amphetamine-amobarbital preparation in the treatment of obesity.
MICHAILE KI; SHAPIRO RP
Int Rec Med Gen Pract Clin; 1956 Oct; 169(10):638-41. PubMed ID: 13366519
[No Abstract] [Full Text] [Related]
20. CONTROL OF OBESITY IN THE CARDIAC PATIENT.
RUSSEK HI
Am J Med Sci; 1965 Mar; 249():305-8. PubMed ID: 14273320
[No Abstract] [Full Text] [Related]
[Next] [New Search]
